Quantitative pharmacokinetics of passive THC absorption;Quantitative pharmakokinetik der passiven THC-aufnahme

Blutalkohol

Volumn 43, Issue 5, 2006, Pages 349-360

  Wehner, Heinz Dieter ^a   Wildemann, Holger ^a   Köhling, Rudolf ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Concentration curve; Disposition parameters; Pharmacokinetic model; Prediction quality; THC absorption (passive)

Indexed keywords

ABSORPTION; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; HUMAN; INHALATION; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MATHEMATICAL PARAMETERS; PREDICTION; QUANTITATIVE ANALYSIS;

EID: 33749634258     PISSN: 00065250     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cone E J, Johnson R E (1986) Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clin Pharmacol Ther 40 (3): 247-56
2. Gibaldi M, Perrier D (1982) Pharmacokinetics. 2nd rev. exp. ed. New York. Basel: Marcel Dekker inc.
3. Holbrook J G (1959, 1966) Laplace Transforms for Electronic Engineers. Oxford: Pergamon Press Ltd.
4. Huestis M A, Henningfield V E, Cane E D (1992) Blood cannabinoids; absorption of THC and formation of 11-OH-THC and THC-COOH during and after smoking marijuana. J Anal Toxicol 16: 276-282
5. Hunt C A, Jones R T (1980) Tolerance and disposition of tetrahydrocannabinol in man. J Pharmacol Exp Ther 215: 35-44
6. Klotz (1984) Klinische Pharmakokinetik. 2nd. rev. exp. ed. Stuttgart. New York: Gustav Fischer Verlag
7. Law B, Mason P A, Moffat A C, et al. (1984) Passive inhalation of cannabis smoke. J Pharm Pharmacol 36 (9): 578-81
8. Mørland J, Bugge A, Skuterud B, et al. (1985) Cannabinoids in blood and urine after passive inhalation of cannabis smoke. J Forensic Sci 30 (4): 997-1002
9. Naef M, Russmann S, Petersen-Felix S, et al. (2004) Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans. J Pharm Sci 93 (5): 1176-84
10. Niedbala S, Kardos K, Salamone S (2004) Passive cannabis smoke exposure and oral fluid testing. J Anal Toxicol 28 (7): 546-52
11. Ohlsson A, Lindren J-E, Wahlen A, et al. (1980) Plasma delta-9-tetrahydrocanna-binol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28: 409-16
12. Perez-Reyes M, Di Guiseppi S, Mason A P, et al. (1983) Passive inhalation of marihuana smoke and urinary excretion of cannabinoids. Clin Pharmacol Ther 34 (1): 36-41
13. Skopp G, Pötsch L (2001) Zur Passivexposition bei der Beurteilung niedriger Cannabinoidkonzentrationen in Blut und Urin. Arch Kriminol 207 (5-6): 137-47
14. Wall M, Sadler B, Brine D, et al. (1983) Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 34 (3): 352-63